Liraglutide for patients with non-alcoholic steatohepatitis.
The Article by Matthew Armstrong and colleagues (Feb 13, p 679) reports different outcomes to those initially registered in the trial protocol.
| Hlavní autoři: | , , |
|---|---|
| Médium: | Journal article |
| Jazyk: | English |
| Vydáno: |
Elsevier
2016
|